Drug intelligence / Profile preview

OTI-20024

Development stage
Preclinical
Lead developer
Ophthalmic Therapeutic Innovation
Modality
Implantable Devices → Device-based Delivery → Drug Delivery Systems
Administration
Intravitreal
01

Overview

OTI-20024 is a preclinical-stage therapeutic candidate developed by Ophthalmic Therapeutic Innovation for the treatment of Non-Arteritic Anterior Ischemic Optic Neuropathy (NAION). The product utilizes a specialized intravitreal (IVT) sustained-release rod (implant) to deliver an undisclosed therapeutic agent directly into the vitreous chamber. This delivery modality is designed to provide prolonged therapeutic levels of the drug to the optic nerve head, aiming to mitigate the vision loss associated with NAION. As of current pipeline disclosures, the specific molecular mechanism of action and the identity of the active pharmaceutical ingredient remain proprietary.

Other names
OTI-20024 IVT rodOTI20024 IVT rodOTI 20024 IVT rodintravitreal (IVT) sustained-release rod

Beyond the preview

Go deeper on OTI-20024.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on OTI-20024.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call